Related Articles
Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in rats
Novel oral plasminogen activator inhibitor‑1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats
Periostin cross‑reacts with the renin‑angiotensin system during liver fibrosis development
Rifaximin enhances the L‑carnitine‑mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut‑liver‑muscle axis
Study on the molecular mechanisms of rifaximin in the treatment of non‑alcoholic steatohepatitis based on the <em>Helicobacter</em>‑DCA‑Fxr‑Hnf1α signalling pathway